Aarti Pharmalabs Limited (NSE:AARTIPHARM)
India · Delayed Price · Currency is INR 980.00
+26.25 (2.75%)
Oct 1, 2026, 3:30 PM IST
Aarti Pharmalabs Revenue
Aarti Pharmalabs had revenue of 5.36B INR in the quarter ending June 30, 2026, with 38.74% growth. This brings the company's revenue in the last twelve months to 19.69B, up 1.20% year-over-year. In the fiscal year ending March 31, 2026, Aarti Pharmalabs had annual revenue of 18.19B, down -13.98%.
Revenue (ttm)
19.69B
Revenue Growth
+1.20%
P/S Ratio
4.46
Revenue / Employee
8.13M
Employees
2,421
Market Cap
87.82B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 18.19B | -2.96B | -13.98% |
| Mar 31, 2025 | 21.15B | 2.62B | 14.17% |
| Mar 31, 2024 | 18.53B | -926.24M | -4.76% |
| Mar 31, 2023 | 19.45B | 7.45B | 62.11% |
| Mar 31, 2022 | 12.00B | - | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Alembic Pharmaceuticals | 77.84B |
| Strides Pharma Science | 50.04B |
| Akums Drugs and Pharmaceuticals | 45.04B |
| NATCO Pharma | 34.85B |
| Eris Lifesciences | 32.12B |
| Alivus Life Sciences | 25.90B |
| Sun Pharma Advanced Research Company | 19.09B |
| Innova Captab | 17.49B |